Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion
| Autor: | Advent International |
|---|---|
| Zdroj: | Business Wire (English). 05/08/2023. |
| Abstrakt: | Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business toAdvent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor. [ABSTRACT FROM PUBLISHER] |
| Databáze: | Regional Business News |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |